XML 25 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (Unaudited) (USD $)
Jun. 30, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 46,444 $ 113,958
Short-term investments 140,510 196,650
Restricted marketable securities 7,400 10,350
Prepaid expenses and other current assets 25,687 3,686
Total current assets 220,041 324,644
Deferred charges 58,984 60,827
Total assets 279,025 385,471
Current liabilities:    
Accounts payable and accrued expenses 1,103,472 1,055,738
Accrued interest on notes payable 4,788 5,630
Note payable, current 118,855  
Deferred revenue 73,731 73,731
Other current liabilities 10,271 13,221
Advances from related party 500,000 500,000
Total current liabilities 1,811,117 1,648,320
Note payable 8,296,735 7,819,960
Deferred revenue, net of current portion 1,105,952 1,142,816
Other long-term liabilities 43,750 43,750
Total liabilities 11,257,554 10,654,846
Commitments and contingencies      
Series F convertible redeemable preferred stock, $.01 par value; 200,000 shares designated; 12,000 shares issued and outstanding at June 30, 2014 and December 31, 2013, (liquidation preference of $300,000 at June 30, 2014) 400,887 390,443
Stockholders' deficit:    
Common stock, $.01 par value; 80,000,000 shares authorized at June 30, 2014 and December 31, 2013; 30,635,720 issued and outstanding at June 30, 2014 and December 31, 2013 306,357 306,357
Additional paid-in capital 188,651,804 188,622,248
Accumulated other comprehensive loss (49,490) 6,650
Deficit accumulated (200,288,087) (199,635,073)
Total stockholders' deficit (11,379,416) (10,659,818)
Total liabilities and stockholders' deficit $ 279,025 $ 385,471